Transparency Market Research Report Added "Dental Pain Market" to its database.
Albany, NY -- (SBWIRE) -- 08/30/2016 -- The global dental pain market is demonstrating vast opportunities as players accelerate their research spending. The market also exhibits lucrative prospects for the entry of new players and novel therapeutics targeting dental pain management. In a report, titled "Dental Pain Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020," Transparency Market Research (TMR) presents a holistic overview of the various factors driving or restraining the market.
Periodontal abscess, occlusal trauma, apical periodontitis, pulpitis, and alveolar osteitis are some of the most common causes of dental pain. Non-dental causes, such as muscle pain, maxillary sinusitis, angina pectoris, psychological disorders, and tumors, can also result in dental pain. Presently, treatments such as root canal therapy, antifungals, antiseptics, phototherapy, antibiotics, and fluoride applications are available to tackle dental pain.
According to the WHO, almost 100% adults worldwide have dental cavities at some point in their life. Severe periodontal ailments are found in almost 15% to 20% of middle-aged people globally. Such increasing burden of oral diseases and dental disorders will support the demand for dental pain management. The prevalence of dental pain and diseases is likely to continue through the forecast period between 2014 and 2020. Leading companies operating in the market are leaving no stone unturned to gain from the situation. As per TMR, strong efforts by research institutes and enterprises will boost the development of novel dental pain management therapies and drugs.
Regionally, North America dominated the global dental pain market in 2014, followed by Europe. Enterprises will continue witnessing lucrative opportunities in North America due to the increasing demand for more effective and minimally-invasive therapies for dental pain in the region. Besides this, technological advancements, easy access to specialized resources, and favorable reimbursement policies have been pivotal in fuelling the demand for dental pain management solutions in Europe and North America alike.
Download Free exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2745
The Centers for Disease Control and Prevention has found that advanced gum diseases affect almost 4% to 12% of the U.S. adults, which is a primary driver for the North America dental pain market. Additionally, the market will gain impetus from the advent of non-surgical and painless treatments of curing dental pain. However, TMR forecasts the Asia Pacific market to see strong gains through 2020. This regional market will benefit from the increasing population recorded by emerging nations, the rising prevalence of oral health problems, increasing disposable income, and accelerating government spending in India and China.
Companies such as Eli Lilly and Company, NeuroDiscovery Ltd., Pfizer, Inc., Bayer AG, Array BioPharma, Inc., Kaken Pharmaceuticals, Pacific Dental Services, and Apollo White Dental are expected to gain significantly from the aforementioned trends.
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453